AAPL277.57+2.42 (+0.88%) ▲|ABBV248.22+5.08 (+2.09%) ▲|ABT94.85+1.61 (+1.73%) ▲|ACN126.29+0.47 (+0.37%) ▲|ADBE197.78+4.37 (+2.26%) ▲|AMAT645.39-22.62 (-3.39%) ▼|AMD519.83-12.74 (-2.39%) ▼|AMGN359.78+6.96 (+1.97%) ▲|AMT173.38+4.66 (+2.76%) ▲|AMZN229.65+2.64 (+1.16%) ▲|AVGO369.53-9.38 (-2.48%) ▼|AXP340.97-1.49 (-0.44%) ▼|BA218.80+0.68 (+0.31%) ▲|BAC57.89-0.31 (-0.52%) ▼|BKNG177.96+0.91 (+0.51%) ▲|BLK973.29+1.37 (+0.14%) ▲|BMY56.74+1.35 (+2.44%) ▲|BNY143.98-1.45 (-1.00%) ▼|BRK-B493.07+5.26 (+1.08%) ▲|C142.87-2.12 (-1.46%) ▼|CAT1,016.19-40.83 (-3.86%) ▼|CL92.12+1.06 (+1.16%) ▲|CMCSA22.73+0.04 (+0.15%) ▲|COF204.68-0.23 (-0.11%) ▼|COP106.23-0.18 (-0.17%) ▼|COST951.69+9.45 (+1.00%) ▲|CRM155.20+5.01 (+3.33%) ▲|CSCO115.75-3.22 (-2.71%) ▼|CVS105.43+0.77 (+0.74%) ▲|CVX170.60-1.64 (-0.95%) ▼|DE623.40-7.36 (-1.17%) ▼|DHR195.26+2.45 (+1.27%) ▲|DIS98.43+0.38 (+0.39%) ▲|DUK127.69+0.58 (+0.45%) ▲|EMR144.82-0.52 (-0.36%) ▼|FDX325.59-3.86 (-1.17%) ▼|GD347.09+2.39 (+0.69%) ▲|GE369.53-1.83 (-0.49%) ▼|GEV1,083.48-1.99 (-0.18%) ▼|GILD127.35+3.51 (+2.83%) ▲|GM79.37+0.84 (+1.07%) ▲|GOOG335.92-6.28 (-1.83%) ▼|GOOGL338.33-5.38 (-1.57%) ▼|GS1,039.99-25.11 (-2.36%) ▼|HD347.31+2.31 (+0.67%) ▲|HON231.51+0.27 (+0.12%) ▲|IBM265.45+7.18 (+2.78%) ▲|INTC130.75-2.12 (-1.60%) ▼|INTU262.42+7.35 (+2.88%) ▲|ISRG405.95+6.26 (+1.57%) ▲|JNJ253.47+8.59 (+3.51%) ▲|JPM332.52-2.60 (-0.78%) ▼|KO81.45+1.03 (+1.28%) ▲|LIN521.55-0.74 (-0.14%) ▼|LLY1,194.14+66.45 (+5.89%) ▲|LMT514.14+9.12 (+1.81%) ▲|LOW221.83-0.11 (-0.05%) ▼|LRCX388.78-13.05 (-3.25%) ▼|MA498.27+9.35 (+1.91%) ▲|MCD265.87+1.33 (+0.50%) ▲|MDLZ61.25+0.05 (+0.08%) ▲|MDT80.71+0.91 (+1.14%) ▲|META544.75+1.88 (+0.35%) ▲|MMM167.39-0.58 (-0.35%) ▼|MO73.42+0.21 (+0.28%) ▲|MRK128.09+2.64 (+2.10%) ▲|MS215.68-5.36 (-2.42%) ▼|MSFT363.24+10.41 (+2.95%) ▲|MU1,195.85-17.71 (-1.46%) ▼|NEE88.04+0.34 (+0.38%) ▲|NFLX73.81+2.91 (+4.10%) ▲|NKE40.69-0.22 (-0.53%) ▼|NOW94.76+5.24 (+5.85%) ▲|NVDA193.88-1.86 (-0.95%) ▼|ORCL150.24-2.22 (-1.46%) ▼|PEP141.30+1.78 (+1.28%) ▲|PFE24.21+0.54 (+2.26%) ▲|PG149.80+1.30 (+0.87%) ▲|PLTR111.13+3.86 (+3.60%) ▲|PM180.51+1.58 (+0.88%) ▲|QCOM206.63+1.73 (+0.84%) ▲|RTX189.40+2.81 (+1.50%) ▲|SBUX103.05-0.11 (-0.11%) ▼|SCHW88.70-0.74 (-0.83%) ▼|SO96.42+0.51 (+0.53%) ▲|SPG226.20+0.71 (+0.31%) ▲|T22.41-0.01 (-0.04%) ▼|TMO510.00+4.25 (+0.84%) ▲|TMUS180.50-1.07 (-0.59%) ▼|TSLA375.44+0.32 (+0.09%) ▲|TXN303.18-8.64 (-2.77%) ▼|UBER73.17+0.92 (+1.27%) ▲|UNH422.41+6.88 (+1.66%) ▲|UNP269.32+1.59 (+0.59%) ▲|UPS108.77-0.54 (-0.49%) ▼|USB61.18-0.03 (-0.05%) ▼|V335.69+5.17 (+1.56%) ▲|VZ46.10+0.03 (+0.05%) ▲|WFC83.84-0.91 (-1.07%) ▼|WMT116.84+1.06 (+0.92%) ▲|XOM136.28-1.27 (-0.92%) ▼|AAPL277.57+2.42 (+0.88%) ▲|ABBV248.22+5.08 (+2.09%) ▲|ABT94.85+1.61 (+1.73%) ▲|ACN126.29+0.47 (+0.37%) ▲|ADBE197.78+4.37 (+2.26%) ▲|AMAT645.39-22.62 (-3.39%) ▼|AMD519.83-12.74 (-2.39%) ▼|AMGN359.78+6.96 (+1.97%) ▲|AMT173.38+4.66 (+2.76%) ▲|AMZN229.65+2.64 (+1.16%) ▲|AVGO369.53-9.38 (-2.48%) ▼|AXP340.97-1.49 (-0.44%) ▼|BA218.80+0.68 (+0.31%) ▲|BAC57.89-0.31 (-0.52%) ▼|BKNG177.96+0.91 (+0.51%) ▲|BLK973.29+1.37 (+0.14%) ▲|BMY56.74+1.35 (+2.44%) ▲|BNY143.98-1.45 (-1.00%) ▼|BRK-B493.07+5.26 (+1.08%) ▲|C142.87-2.12 (-1.46%) ▼|CAT1,016.19-40.83 (-3.86%) ▼|CL92.12+1.06 (+1.16%) ▲|CMCSA22.73+0.04 (+0.15%) ▲|COF204.68-0.23 (-0.11%) ▼|COP106.23-0.18 (-0.17%) ▼|COST951.69+9.45 (+1.00%) ▲|CRM155.20+5.01 (+3.33%) ▲|CSCO115.75-3.22 (-2.71%) ▼|CVS105.43+0.77 (+0.74%) ▲|CVX170.60-1.64 (-0.95%) ▼|DE623.40-7.36 (-1.17%) ▼|DHR195.26+2.45 (+1.27%) ▲|DIS98.43+0.38 (+0.39%) ▲|DUK127.69+0.58 (+0.45%) ▲|EMR144.82-0.52 (-0.36%) ▼|FDX325.59-3.86 (-1.17%) ▼|GD347.09+2.39 (+0.69%) ▲|GE369.53-1.83 (-0.49%) ▼|GEV1,083.48-1.99 (-0.18%) ▼|GILD127.35+3.51 (+2.83%) ▲|GM79.37+0.84 (+1.07%) ▲|GOOG335.92-6.28 (-1.83%) ▼|GOOGL338.33-5.38 (-1.57%) ▼|GS1,039.99-25.11 (-2.36%) ▼|HD347.31+2.31 (+0.67%) ▲|HON231.51+0.27 (+0.12%) ▲|IBM265.45+7.18 (+2.78%) ▲|INTC130.75-2.12 (-1.60%) ▼|INTU262.42+7.35 (+2.88%) ▲|ISRG405.95+6.26 (+1.57%) ▲|JNJ253.47+8.59 (+3.51%) ▲|JPM332.52-2.60 (-0.78%) ▼|KO81.45+1.03 (+1.28%) ▲|LIN521.55-0.74 (-0.14%) ▼|LLY1,194.14+66.45 (+5.89%) ▲|LMT514.14+9.12 (+1.81%) ▲|LOW221.83-0.11 (-0.05%) ▼|LRCX388.78-13.05 (-3.25%) ▼|MA498.27+9.35 (+1.91%) ▲|MCD265.87+1.33 (+0.50%) ▲|MDLZ61.25+0.05 (+0.08%) ▲|MDT80.71+0.91 (+1.14%) ▲|META544.75+1.88 (+0.35%) ▲|MMM167.39-0.58 (-0.35%) ▼|MO73.42+0.21 (+0.28%) ▲|MRK128.09+2.64 (+2.10%) ▲|MS215.68-5.36 (-2.42%) ▼|MSFT363.24+10.41 (+2.95%) ▲|MU1,195.85-17.71 (-1.46%) ▼|NEE88.04+0.34 (+0.38%) ▲|NFLX73.81+2.91 (+4.10%) ▲|NKE40.69-0.22 (-0.53%) ▼|NOW94.76+5.24 (+5.85%) ▲|NVDA193.88-1.86 (-0.95%) ▼|ORCL150.24-2.22 (-1.46%) ▼|PEP141.30+1.78 (+1.28%) ▲|PFE24.21+0.54 (+2.26%) ▲|PG149.80+1.30 (+0.87%) ▲|PLTR111.13+3.86 (+3.60%) ▲|PM180.51+1.58 (+0.88%) ▲|QCOM206.63+1.73 (+0.84%) ▲|RTX189.40+2.81 (+1.50%) ▲|SBUX103.05-0.11 (-0.11%) ▼|SCHW88.70-0.74 (-0.83%) ▼|SO96.42+0.51 (+0.53%) ▲|SPG226.20+0.71 (+0.31%) ▲|T22.41-0.01 (-0.04%) ▼|TMO510.00+4.25 (+0.84%) ▲|TMUS180.50-1.07 (-0.59%) ▼|TSLA375.44+0.32 (+0.09%) ▲|TXN303.18-8.64 (-2.77%) ▼|UBER73.17+0.92 (+1.27%) ▲|UNH422.41+6.88 (+1.66%) ▲|UNP269.32+1.59 (+0.59%) ▲|UPS108.77-0.54 (-0.49%) ▼|USB61.18-0.03 (-0.05%) ▼|V335.69+5.17 (+1.56%) ▲|VZ46.10+0.03 (+0.05%) ▲|WFC83.84-0.91 (-1.07%) ▼|WMT116.84+1.06 (+0.92%) ▲|XOM136.28-1.27 (-0.92%) ▼|
20.5 C
New York
Friday, June 26, 2026

Tag: compensation

newssourceFORcompanyinformationcontent1marketreleases

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of July 17, 2025, the Compensation Committee of the Board of Directors granted Qing Zuraw, M.D., the Company’s Chief Development Officer, 4,373,040 stock options and 937,080 restricted stock units (“RSUs”) in connection with the commencement of her employment. The foregoing stock option and RSU awards were granted as a material inducement to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).

Visteon Names Marjorie Sennett to Board of Directors

Distinguished finance and technology executive joins board of global automotive electronics leader VAN BUREN TOWNSHIP, Mich., July 18, 2025 /PRNewswire/ -- Visteon Corporation (NASDAQ: VC),...

Autoliv: Financial Report April – June 2025

STOCKHOLM, July 18, 2025 /PRNewswire/ -- Q2 2025: Q2 records for sales, operating income and margin as well as EPS Financial highlights Q2 2025$2,714 million net...

Discounted Explorers Poised For Catch‑Up Rally In Bullish Gold Market

USA News Group News CommentaryIssued on behalf of RUA GOLD Inc. VANCOUVER, BC, July 17, 2025 /PRNewswire/ -- USA News Group News Commentary – After a...

Discounted Explorers Poised For Catch‑Up Rally In Bullish Gold Market

USA News Group News CommentaryIssued on behalf of RUA GOLD Inc. VANCOUVER, BC, July 17, 2025 /CNW/ -- USA News Group News Commentary – After a...

Discounted Explorers Poised For Catch‑Up Rally In Bullish Gold Market

USA News Group News CommentaryIssued on behalf of RUA GOLD Inc. VANCOUVER, BC, July 17, 2025 /PRNewswire/ -- USA News Group News Commentary – After a...

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages iRobot Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRBT

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between January 29, 2024 and March 11, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 5, 2025.

ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HIMS

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

Rosen Law Firm Urges Biohaven Ltd. (NYSE: BHVN) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK, July 16, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research...

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /CNW/ -- As lawmakers weigh potential cuts to scientific research...

From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 16, 2025 /PRNewswire/ -- Equity Insider News Commentary – Increased usage of AI...

Get a $1,000 Quick Loan: No Credit Check Lenders in the US

Explore a $1,000 Quick Loan from Honest Loans – No Credit Check Needed for Eligible US Borrowers in 2025 
Explore a $1,000 Quick Loan from Honest Loans – No Credit Check Needed for Eligible US Borrowers in 2025

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompensation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers